Irwin Naturals Inc
CNSX:IWIN
Intrinsic Value
Irwin Naturals, Inc. engages in the distribution of herbal supplement. [ Read More ]
The intrinsic value of one IWIN stock under the Base Case scenario is 0.66 CAD. Compared to the current market price of 0.3 CAD, Irwin Naturals Inc is Undervalued by 54%.
Valuation Backtest
Irwin Naturals Inc
Run backtest to discover the historical profit from buying and selling IWIN stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Irwin Naturals Inc
| Current Assets | 37.9m |
| Cash & Short-Term Investments | 5.5m |
| Receivables | 13m |
| Other Current Assets | 19.5m |
| Non-Current Assets | 32.9m |
| PP&E | 3.5m |
| Intangibles | 15.2m |
| Other Non-Current Assets | 14.2m |
| Current Liabilities | 48.4m |
| Accounts Payable | 14.6m |
| Accrued Liabilities | 5.5m |
| Short-Term Debt | 25.7m |
| Other Current Liabilities | 2.7m |
| Non-Current Liabilities | 15.3m |
| Long-Term Debt | 2.3m |
| Other Non-Current Liabilities | 13m |
Earnings Waterfall
Irwin Naturals Inc
|
Revenue
|
86.7m
USD
|
|
Cost of Revenue
|
-48.4m
USD
|
|
Gross Profit
|
38.3m
USD
|
|
Operating Expenses
|
-46.2m
USD
|
|
Operating Income
|
-7.8m
USD
|
|
Other Expenses
|
-11.5m
USD
|
|
Net Income
|
-19.3m
USD
|
Free Cash Flow Analysis
Irwin Naturals Inc
IWIN Profitability Score
Profitability Due Diligence
Irwin Naturals Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
Score
Irwin Naturals Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
IWIN Solvency Score
Solvency Due Diligence
Irwin Naturals Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Score
Irwin Naturals Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IWIN Price Targets Summary
Irwin Naturals Inc
Shareholder Return
IWIN Price
Irwin Naturals Inc
| Average Annual Return | 14.57% |
| Standard Deviation of Annual Returns | 28.26% |
| Max Drawdown | -98% |
| Market Capitalization | 159m CAD |
| Shares Outstanding | 530 032 190 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Irwin Naturals, Inc. engages in the distribution of herbal supplement. The company is headquartered in Los Angeles, California and currently employs 111 full-time employees. The firm is engaged in distributing cannabidiol (CBD) products in mass-market and health food chain stores across the United States. Irwin's portfolio of herbal products are available in more than 100,000 retail doors across North America. The firm's full range of Vitamin, CBD, and Supplements features over 100 products, created to address mood and brain function, better sleep, sports performance, sexual health, immune support, weight management, women's health and men's health. The firm's ketamine clinic, Emergence, is an infusion clinic that offers intravenous (IV) ketamine for the treatment of depression, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), anxiety, bipolar disorder, migraines, and multiple chronic pain conditions such as complex regional pain syndrome (CRPS), reflex sympathetic dystrophy (RSD) and fibromyalgia.
Contact
IPO
Employees
Officers
The intrinsic value of one IWIN stock under the Base Case scenario is 0.66 CAD.
Compared to the current market price of 0.3 CAD, Irwin Naturals Inc is Undervalued by 54%.
You don't have any saved screeners yet
